FIELD: medicine. SUBSTANCE: described are new compounds which are 2-amino-1,2,3,4- tetrahydronaphthalene derivatives of formula I: 
intended for medical treatment of arterial hypertension, myocardial deficiency, kidney deficiency, peripheral arteriopathies or cerebrovascular deficiencies. Said compounds have activities and prolonged activity and are capable of being absorbed when administered orally. EFFECT: improved properties of the title compounds. 7 cl, 100 ex, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| 2-AMINO-1,2,3,4-TETRAHYDRONAPHTALENE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, AND COMPOSITION HAVING CARDIOVASCULAR ACTIVITY | 1993 |
|
RU2120435C1 |
| 9-O-OXIME DERIVATIVES OF ERYTHTROMYCIN A AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1995 |
|
RU2152951C1 |
| RESORCINOL DERIVATIVE AS HSP90 INHIBITOR | 2016 |
|
RU2697703C2 |
| 9A-AZALIDES ELICITING ANTI-INFLAMMATORY ACTIVITY | 2003 |
|
RU2320668C2 |
| MANNOSE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS | 2014 |
|
RU2678327C2 |
| KINASE INHIBITORS | 2013 |
|
RU2637944C2 |
| TETRAHYDROTRIAZOLOPYRIMIDINE DERIVATIVES AS INHIBITORS OF HUMAN NEUTROPHIL ELASTASE | 2012 |
|
RU2622643C2 |
| METHODS FOR PRODUCTION OF RACEMIC AMINOSUBSTITUTED 5,6,7,8-TETRAHYDROQUINOLINE OR RACEMIC AMINOSUBSTITUTED 5,6,7,8-TETRAHYDROISOQUINOLINE, METHODS FOR SEPARATION AND RACEMIZATION THEREOF, METHODS FOR PRODUCTION OF KETOSUBSTITUTED 5,6,7,8-TETRAHYDROQUINOLINE OR KETOSUBSTITUTED 5,6,7,8-TETRAHYDROISOQUINOLINE, METHOD FOR PRODUCTION OF ENANTIOMER PF CONDENSED BYCYCLIC RING SUBSTITUTED WITH PRIMARY AMINE, 5,6,7,8-TETRAHYDROQUINOLINE DERIVATIVES | 2002 |
|
RU2308451C2 |
| SECONDARY MANNOSIS FOR BACTERIAL INFECTIONS TREATMENT | 2013 |
|
RU2667060C2 |
| SUBSTITUTED 2-AMINOPYRIDINE PROTEIN KINASE INHIBITOR | 2014 |
|
RU2671212C2 |
